The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: Correlation with transrectal ultrasound and pathological findings

Diagnostic and Interventional Radiology

Volumn 17, Issue 1, 2011, Pages 38-43

  Kara, Taylan ^a   Akata, Deniz ^a   Akyol, Fadil ^a   Karçaaltincaba, Muşturay ^a   Özmen, Mustafa ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Magnetic resonance imaging; Prostatic neoplasms; Radiotherapy; Transrectal ultrasonography

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; CONTRAST MEDIA; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 79952031671     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.3079-09.1     Document Type: Article

References (25)

1. Coakley FV, Teh HS, Qayyum A, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 2004; 233:441-448.
2. Stephenson RA, Stanford JL. Populationbased prostate cancer trends in the United States: patterns of the change in the era of prostate-specific antigen. World J Urol 1997; 15:331-335.
3. Mettlin CJ, Murphy GP, Mcdonald CJ, et al. The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the US. Cancer 1999; 86:1877-1882
4. D'Amico AV, Crook J, Beard CJ, DeWeese TL, Hurwitz M, Kaplan I. Radiation therapy for prostate cancer. In: Walsh PC, Retik AB, Vaughan ED, et al. eds. Campbell's urology. 8th ed. Philadelphia: Saunders, 2002; 3147-3170.
5. Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002; 224:701-706.
6. Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994; 193:703-709.
7. Crook J, Robertson S, Collin G, et al. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate specific antigen following external beam radiotherapy for carcinoma of the Prostate. Int J Radiat Oncol Biol Phys 1993; 27:31-37.
8. Nudell DM, Wefer AE, Hricak H, Carroll PR. Imaging for recurrent prostate cancer. Radiol Clin North Am 2000; 38:213-229.
9. Rifkin MD, Zerhouni EA, Gatsonis CA, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 1990; 323:621-626.
10. Fütterer JJ, Engelbrecht MR, Jager GJ, et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 2007; 17:1055-1065.
11. Cheng D, Tempany CMC. MR imaging of the prostate and bladder. Semin Ultrasound CT MR 1998; 19:67-89.
12. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and H MR spectroscopy. Radiographics 2004; 24:167-180.
13. Westphalen AC, Kurhanewicz J, Cunha MGR, et al. T2-weighted endorectal magnetic resonance imaging of the prostate cancer after external beam radiation therapy. Int Braz J Urol 2009; 35:171-182.
14. Haider MA, Chung P, Sweet J, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70:425-430.
15. Rouvière O. MR assessment of recurrent prostate cancer after radiation therapy. Radiology 2007; 242:635-636.
16. Coakley FV, Hricak H, Wefer AE, et al. Brachytherapy for prostate cancer: endorectal MR imaging of local treatmentrelated changes. Radiology 2001; 219:817- 821.
17. Fütterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005; 237:541-549.
18. Rouvière O, Valette O, Grivolat S, et al. Recurrent prostate cancer after external beam radiotherapy: Value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor correlation with biopsy findings. Urology 2004; 63 922-927.
19. Pucar D, Shukla-Dave A, Hricak H, et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 2005; 236:545-553.
20. Turkbey B, Albert PS, Kurdziel K, Choyke PL. Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 2009; 192:1471-1480.
21. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on stepsection pathologic analysis after radical prostatectomy. Radiology 2005; 234:804- 814.
22. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002; 16:451-463.
23. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheric zones of the prostate. J Magn Reson Imaging 2005; 21:258-262.
24. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheric zone tissue. J Magn Reson Imaging 2004; 20:654-661.
25. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007; 243:28-53.